以木药物为灵感的超微型德克斯涂层木氧化物纳米颗粒用于针对性计算机断层扫描对炎症性肠病的成像
Gang Shu1, Cai Zhang2, Ya Wen3
1School of Medical Imaging, Tianjin Key Laboratory of Functional Imaging, Tianjin Medical University, Tianjin, 300203, China; Department of Radiology, The Second Hospital of Tianjin Medical University, Tianjin, 300211, China.
我们开发了超小的甲涂层氧化纳米颗粒 (Bi2O3-Dex NPs) 用于针对性计算机断层扫描 (CT) 对炎症性肠病 (IBD) 的成像. 这些纳米粒子提供了增强的可视化和在炎症部位的特定积累.
科学领域:
- 纳米技术纳米技术
- 生物医学成像技术 生物医学成像技术
- 材料科学 材料科学 材料科学
背景情况:
- 基于 (Bi) 的对比剂 (CA) 显示出由于成本效益,灵敏度和生物相容性,对胃肠道 (GI) 疾病的诊断有希望.
- 临床翻译面临的挑战包括合成,水溶性和基于Bi的CA的向.
研究的目的:
- 开发超小的甲涂层氧化纳米颗粒 (Bi2O3-Dex NPs) 用于针对性计算机断层扫描 (CT) 对炎症性肠病 (IBD) 的成像.
- 解决当前基于Bi的CA的合成,溶解度和准限制.
主要方法:
- Bi2O3-Dex NPs通过一种简单的性沉反应,使用比斯穆特盐和德克斯来合成.
- 描述包括尺寸,水溶性,Bi含量,生物相容性和X射线衰减能力.
- 在体内研究涉及口服给大肠炎小鼠,用于消化道和炎症部位的CT成像.
主要成果:
- 合成的Bi2O3-DexNP是超小的 (3.4纳米),具有特殊的水溶性 (>200毫克毫升-1),高Bi含量 (19.75%),以及出色的生物相容性.
- Bi2O3-Dex NPs显示出比临床IOHEXOL更高的X射线衰减.
- CT成像清楚地可视化了胃肠道和肠道结构,在结肠炎模型中对炎症部位进行了特定的向和积累.
结论:
- Bi2O3-Dex NP代表了一种新的,简单的,临床上有前途的诊断肠道疾病的策略.
- 开发的纳米粒子克服了基于Bi的CA的关键局限性,使得IBD的向CT成像成为可能.
- 这种方法为先进的胃肠道诊断提供了高性能解决方案.
更多相关视频
09:01Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
07:26Synthesis of 68Ga Core-doped Iron Oxide Nanoparticles for Dual Positron Emission Tomography /T1Magnetic Resonance Imaging
Published on: November 20, 2018
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Ulcerative Colitis in IBD
